Should I buy or sell Teleflex stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TFX shares. View TFX analyst ratings or view top-rated stocks .

What is Teleflex's stock price target for 2024?

10 equities research analysts have issued 12-month price targets for Teleflex's shares. Their TFX share price targets range from $225.00 to $293.00. On average, they anticipate the company's share price to reach $265.56 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price. View analysts price targets for TFX or view top-rated stocks among Wall Street analysts .

How have TFX shares performed in 2024?

Teleflex's stock was trading at $249.34 at the beginning of 2024. Since then, TFX shares have decreased by 15.4% and is now trading at $210.83. View the best growth stocks for 2024 here .

Are investors shorting Teleflex?

Teleflex saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 817,200 shares, a drop of 42.0% from the February 29th total of 1,410,000 shares. Based on an average trading volume of 250,100 shares, the days-to-cover ratio is currently 3.3 days. View Teleflex's Short Interest .

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our TFX earnings forecast .

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings results on Thursday, February, 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts' consensus estimates of $3.26 by $0.12. The medical technology company had revenue of $773.90 million for the quarter, compared to analysts' expectations of $769.01 million. Teleflex had a net margin of 11.98% and a trailing twelve-month return on equity of 14.98%. The company's revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.52 earnings per share. Read the conference call transcript .

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, February 22nd. Shareholders of record on Friday, March 1st will be paid a dividend of $0.34 per share on Friday, March 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, February 29th. Read our dividend analysis for TFX .

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.63%. The dividend payout ratio is 18.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 8.95% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for TFX .

What ETFs hold Teleflex's stock?

ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) , First Trust Indxx Medical Devices ETF (MDEV) , SPDR S&P Health Care Equipment ETF (XHE) , Invesco S&P 500 Equal Weight Health Care ETF (RYH) , Invesco S&P 500 Equal Weight Health Care ETF (RSPH) , iShares U.S. Medical Devices ETF (IHI) , T. Rowe Price Capital Appreciation Equity ETF (TCAF) and Mid Cap US Equity Select ETF (RNMC) .

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY24 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of $13.55-$13.95 for the period, compared to the consensus EPS estimate of $13.73.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com . Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA) , AbbVie (ABBV) , Johnson & Johnson (JNJ) , Alibaba Group (BABA) , Lam Research (LRCX) , ServiceNow (NOW) , QUALCOMM (QCOM) , Advanced Micro Devices (AMD) , Salesforce (CRM) and Cisco Systems (CSCO) .

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of institutional and retail investors. Top institutional investors include Mountain Pacific Investment Advisers Inc. ID (0.17%), Bridge Creek Capital Management LLC (0.03%), Rowlandmiller & PARTNERS.ADV (0.02%), Congress Asset Management Co. MA (0.01%), Washington Capital Management Inc. (0.01%) and Thompson Investment Management Inc. (0.01%). Insiders that own company stock include Andrew A Krakauer , Cameron P Hicks , Liam Kelly , Stephen K MD Klasko, Stephen K MD Klasko , Stuart A Randle and Thomas E Powell . View institutional ownership trends .

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:TFX

Teleflex (TFX) Stock Price, News & Analysis

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Free TFX Stock Alerts

$210.91

+0.25 (+0.12%)

(As of 03:51 PM ET)

Compare

Today's Range: $207.79
▼
$213.23
50-Day Range: $210.66
▼
$255.15
52-Week Range: $177.63
▼
$276.43

Volume: 137,115 shs
Average Volume: 258,449 shs
Market Capitalization: $9.93 billion

P/E Ratio: 28.01
Dividend Yield: 0.64%
Price Target: $265.56

Get Teleflex alerts:

Teleflex MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.60 Rating Score
Upside/Downside: 26.0% Upside
$265.56 Price Target
Short Interest: Healthy
1.89% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.53
Upright™ Environmental Score
News Sentiment: 1.11
Based on 5 Articles This Week
Insider Trading: Selling Shares
$1.67 M Sold Last Quarter
Proj. Earnings Growth: 10.71%
From $13.73 to $15.20 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.76 out of 5 stars

Medical Sector

44th out of 930 stocks

Surgical & Medical Instruments Industry

7th out of 99 stocks

3.3

Analyst's Opinion

Consensus Rating
Teleflex has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 6 buy ratings, 4 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Teleflex has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.89% of the outstanding shares of Teleflex have been sold short.
Short Interest Ratio / Days to Cover
Teleflex has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Teleflex has recently increased by 8.69%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
Teleflex has a dividend yield of 0.63%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Teleflex does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Teleflex is 18.06%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Teleflex will have a dividend payout ratio of 8.95% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Teleflex has received a 53.08% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wound closure devices", "Surgical clamps", and "Catheters" products. See details.
Environmental Sustainability
The Environmental Impact score for Teleflex is -1.53.

2.3

News and Social Media Coverage

News Sentiment
Teleflex has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Teleflex this week, compared to 6 articles on an average week.
MarketBeat Follows
Only 2 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Teleflex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,665,225.00 in company stock.
Percentage Held by Insiders
Only 1.43% of the stock of Teleflex is held by insiders.
Percentage Held by Institutions
95.62% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Teleflex are expected to grow by 10.71% in the coming year, from $13.73 to $15.20 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Teleflex is 28.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 137.63.
Price to Earnings Ratio vs. Sector
The P/E ratio of Teleflex is 28.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 199.64.
Price to Earnings Growth Ratio
Teleflex has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Teleflex has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Teleflex Stock (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TFX Stock News Headlines

April 13, 2024 | nasdaq.com

Guru Fundamental Report for TFX - Benjamin Graham

April 5, 2024 | msn.com

Teleflex Unveils Advanced Tissue Control for UroLift 2 System, Revolutionizing BPH Treatment

April 16, 2024 | Crypto Swap Profits (Ad)

Did You Get Your Free Bitcoin Yet?

April 2, 2024 | finance.yahoo.com

Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types

April 1, 2024 | msn.com

Teleflex Sets Ambitious Climate Targets, Validated by Science Based Targets Initiative

March 28, 2024 | finance.yahoo.com

Teleflex’s Climate Targets Validated by the Science Based Targets Initiative

March 28, 2024 | globenewswire.com

Teleflex's Climate Targets Validated by the Science Based Targets Initiative

March 24, 2024 | finance.yahoo.com

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 60% Above Its Share Price

April 16, 2024 | Crypto Swap Profits (Ad)

Did You Get Your Free Bitcoin Yet?

March 19, 2024 | finance.yahoo.com

Teleflex Incorporated: Teleflex: Fair Value Estimate Revised Upward; Outlook Strong, but Acquisitions Warrant Scrutiny

March 16, 2024 | nasdaq.com

Guru Fundamental Report for TFX

March 14, 2024 | stockhouse.com

Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)

March 3, 2024 | finance.yahoo.com

TFX Mar 2024 200.000 put

February 28, 2024 | nasdaq.com

Teleflex Enters Oversold Territory (TFX)

February 28, 2024 | finance.yahoo.com

TFX Jul 2024 300.000 call

February 26, 2024 | benzinga.com

Teleflex: Dividend Insights

February 24, 2024 | finance.yahoo.com

Decoding Teleflex Inc (TFX): A Strategic SWOT Insight

February 23, 2024 | markets.businessinsider.com

RBC Capital Reaffirms Their Buy Rating on Teleflex (TFX)

February 23, 2024 | finance.yahoo.com

Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript

February 23, 2024 | msn.com

Teleflex Earnings Transcript (NYSE:TFX)

February 23, 2024 | markets.businessinsider.com

Teleflex Hold Rating Justified Amidst Modest Growth and Multiple Headwinds

February 23, 2024 | markets.businessinsider.com

Breaking Down Teleflex: 4 Analysts Share Their Views

February 23, 2024 | finance.yahoo.com

Q4 2023 Teleflex Inc Earnings Call

February 22, 2024 | markets.businessinsider.com

Teleflex Inc Q4 Profit Decreases, but beats estimates

February 22, 2024 | finance.yahoo.com

Teleflex Announces Quarterly Dividend

February 22, 2024 | markets.businessinsider.com

Teleflex Q4 Results Top Estimates: Guides FY24 In Line With View

February 22, 2024 | msn.com

Teleflex Non-GAAP EPS of $3.38 beats by $0.12, revenue of $773.9M beats by $5.2M

See More Headlines

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/22/2024
Ex-Dividend for 3/15 Dividend: 2/29/2024
Dividend Payable: 3/15/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Current Symbol: NYSE:TFX
CUSIP: 87936910
CIK: 96943
Web: www.teleflex.com
Phone: (610) 225-6800
Fax: 215-553-5402
Employees: 14,500
Year Founded: 1943

Price Target and Rating

Average Stock Price Target: $265.56
High Stock Price Target: $293.00
Low Stock Price Target: $225.00
Potential Upside/Downside: +26.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.60
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $7.53
Trailing P/E Ratio: 27.98
Forward P/E Ratio: 15.34
P/E Growth: 2.05
Net Income: $356.33 million
Net Margins: 11.98%
Pretax Margin: 14.59%
Return on Equity: 14.98%
Return on Assets: 8.87%

Debt

Debt-to-Equity Ratio: 0.39
Current Ratio: 2.32
Quick Ratio: 1.29

Sales & Book Value

Annual Sales: $2.97 billion
Price / Sales: 3.34
Cash Flow: $18.50 per share
Price / Cash Flow: 11.39
Book Value: $94.49 per share
Price / Book: 2.23

Miscellaneous

Outstanding Shares: 47,100,000
Free Float: 46,427,000
Market Cap: $9.92 billion
Optionable: Optionable
Beta: 1.11

Social Links

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Liam J. Kelly (Age 57)
Chairman, President & CEO
Comp: $2M
Mr. Thomas E. Powell BS (Age 62)
MBA, Executive VP & CFO
Comp: $1.04M
Mr. Cameron P. Hicks (Age 59)
Corporate Vice President of Human Resources & Communications
Comp: $564.68k
Mr. Jay White (Age 50)
Corporate VP & President of Global Commercial
Comp: $866.86k
Mr. John R. Deren
Corporate VP & Chief Accounting Officer
Mr. Timothy F. Duffy
VP & Chief Information Officer
Mr. Daniel V. Logue (Age 50)
Corporate VP, General Counsel & Secretary
Mr. Howard Cyr
Corporate VP & Chief Compliance Officer
Mr. James Ferguson
President & GM of Surgical
Ms. Michelle Fox
Corporate VP & Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

TFX Stock Analysis - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?: 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TFX shares.
View TFX analyst ratings or view top-rated stocks.
What is Teleflex's stock price target for 2024?: 10 equities research analysts have issued 12-month price targets for Teleflex's shares. Their TFX share price targets range from $225.00 to $293.00. On average, they anticipate the company's share price to reach $265.56 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.
How have TFX shares performed in 2024?: Teleflex's stock was trading at $249.34 at the beginning of 2024. Since then, TFX shares have decreased by 15.4% and is now trading at $210.83.
View the best growth stocks for 2024 here.
Are investors shorting Teleflex?: Teleflex saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 817,200 shares, a drop of 42.0% from the February 29th total of 1,410,000 shares. Based on an average trading volume of 250,100 shares, the days-to-cover ratio is currently 3.3 days.
View Teleflex's Short Interest.
When is Teleflex's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our TFX earnings forecast.
How were Teleflex's earnings last quarter?: Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings results on Thursday, February, 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts' consensus estimates of $3.26 by $0.12. The medical technology company had revenue of $773.90 million for the quarter, compared to analysts' expectations of $769.01 million. Teleflex had a net margin of 11.98% and a trailing twelve-month return on equity of 14.98%. The company's revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.52 earnings per share.
Read the conference call transcript.
How often does Teleflex pay dividends? What is the dividend yield for Teleflex?: Teleflex announced a quarterly dividend on Thursday, February 22nd. Shareholders of record on Friday, March 1st will be paid a dividend of $0.34 per share on Friday, March 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, February 29th.
Read our dividend analysis for TFX.
Is Teleflex a good dividend stock?: Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.63%. The dividend payout ratio is 18.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 8.95% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What ETFs hold Teleflex's stock?: ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), First Trust Indxx Medical Devices ETF (MDEV), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), iShares U.S. Medical Devices ETF (IHI), T. Rowe Price Capital Appreciation Equity ETF (TCAF) and Mid Cap US Equity Select ETF (RNMC).
What guidance has Teleflex issued on next quarter's earnings?: Teleflex issued an update on its FY24 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of $13.55-$13.95 for the period, compared to the consensus EPS estimate of $13.73.
What is Liam Kelly's approval rating as Teleflex's CEO?: 73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.
What other stocks do shareholders of Teleflex own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).
Who are Teleflex's major shareholders?: Teleflex's stock is owned by a number of institutional and retail investors. Top institutional investors include Mountain Pacific Investment Advisers Inc. ID (0.17%), Bridge Creek Capital Management LLC (0.03%), Rowlandmiller & PARTNERS.ADV (0.02%), Congress Asset Management Co. MA (0.01%), Washington Capital Management Inc. (0.01%) and Thompson Investment Management Inc. (0.01%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends.
How do I buy shares of Teleflex?: Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:TFX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Teleflex (TFX) Stock Price, News & Analysis

Teleflex MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Teleflex Stock (NYSE:TFX)

TFX Stock Price History

TFX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

TFX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™